mcCormick Shawn — SEC Form 4 filings
SEC reporting owner CIK 1454092. 12 Form 4 filings on record with FilingPulse; latest filed 2026-05-11.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-05-06 to 2026-05-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 5,056 shares, $686,896 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 2,000 shares @ $127.48 ($254,960) in Inspire Medical Systems, Inc., filed 2025-12-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | Director | 10 | — | 5 legs · 5,056 sh · $686,896 | 10 |
| NEVRO CORP (NVRO) | Director | 2 | — | — | 2 |
Form 4 filings — mcCormick Shawn
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-11 | 4 | Inspire Medical Systems, Inc. (INSP) | Sale (S): 696 @ $45.31 | EDGAR |
| 2026-05-04 | 4 | Inspire Medical Systems, Inc. (INSP) | Grant/award (A): 3,562 @ $0 | EDGAR |
| 2025-12-04 | 4 | Inspire Medical Systems, Inc. (INSP) | Sale (S): 1,200 @ $139 | EDGAR |
| 2025-12-01 | 4 | Inspire Medical Systems, Inc. (INSP) | Sale (S): 2,000 @ $127.48 | EDGAR |
| 2025-06-06 | 4 | Inspire Medical Systems, Inc. (INSP) | Option exercise (M): 4,000 @ $16 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | Inspire Medical Systems, Inc. (INSP) | Grant/award (A): 1,266 @ $0 · Sale (S): 360 @ $160 | EDGAR |
| 2025-04-03 | 4 | NEVRO CORP (NVRO) | Disposition to issuer (D): 46,035 | EDGAR |
| 2024-09-11 | 4 | Inspire Medical Systems, Inc. (INSP) | Sale (S): 800 @ $220 | EDGAR |
| 2024-08-15 | 4 | Inspire Medical Systems, Inc. (INSP) | Option exercise (M): 8,537 @ $0.94 · Option exercise (M): 1,019 (derivative) @ $0 · Option exercise (M): 7,518 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | NEVRO CORP (NVRO) | Grant/award (A): 19,169 @ $0 | EDGAR |
| 2024-05-13 | 4 | Inspire Medical Systems, Inc. (INSP) | Option exercise (M): 2,500 @ $0.94 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | Inspire Medical Systems, Inc. (INSP) | Grant/award (A): 716 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1454092 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →